BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 15368070)

  • 1. Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies.
    Kersaitis C; Halliday GM; Kril JJ
    Acta Neuropathol; 2004 Dec; 108(6):515-23. PubMed ID: 15368070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astrocytic degeneration relates to the severity of disease in frontotemporal dementia.
    Broe M; Kril J; Halliday GM
    Brain; 2004 Oct; 127(Pt 10):2214-20. PubMed ID: 15282215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of brain atrophy in behavioral variant frontotemporal dementia.
    Kril JJ; Macdonald V; Patel S; Png F; Halliday GM
    J Neurol Sci; 2005 May; 232(1-2):83-90. PubMed ID: 15850587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation.
    Shi J; Shaw CL; Du Plessis D; Richardson AM; Bailey KL; Julien C; Stopford C; Thompson J; Varma A; Craufurd D; Tian J; Pickering-Brown S; Neary D; Snowden JS; Mann DM
    Acta Neuropathol; 2005 Nov; 110(5):501-12. PubMed ID: 16222525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin-positive neuronal and tau 2-positive glial inclusions in frontotemporal dementia of motor neuron type.
    Forno LS; Langston JW; Herrick MK; Wilson JD; Murayama S
    Acta Neuropathol; 2002 Jun; 103(6):599-606. PubMed ID: 12012092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical ubiquitin-positive inclusions in frontotemporal dementia without motor neuron disease: a quantitative immunocytochemical study.
    Kövari E; Gold G; Giannakopoulos P; Bouras C
    Acta Neuropathol; 2004 Sep; 108(3):207-12. PubMed ID: 15170577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinico-pathological investigation of two patients with dementia with motor neuron disease].
    Yamamoto R; Iseki E; Murayama N; Minegishi M; Kimura M; Eto K; Arai H; Ohbu S; Hatanaka D; Hino H; Fujisawa K
    Brain Nerve; 2007 Mar; 59(3):263-9. PubMed ID: 17370652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frontotemporal dementia with co-occurrence of astrocytic plaques and tufted astrocytes, and severe degeneration of the cerebral white matter: a variant of corticobasal degeneration?
    Tan CF; Piao YS; Kakita A; Yamada M; Takano H; Tanaka M; Mano A; Makino K; Nishizawa M; Wakabayashi K; Takahashi H
    Acta Neuropathol; 2005 Mar; 109(3):329-38. PubMed ID: 15841415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontotemporal lobar degeneration and ubiquitin immunohistochemistry.
    Josephs KA; Holton JL; Rossor MN; Godbolt AK; Ozawa T; Strand K; Khan N; Al-Sarraj S; Revesz T
    Neuropathol Appl Neurobiol; 2004 Aug; 30(4):369-73. PubMed ID: 15305982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal and glial tau pathology in early frontotemporal lobar degeneration-tau, Pick's disease subtype.
    Mimuro M; Yoshida M; Miyao S; Harada T; Ishiguro K; Hashizume Y
    J Neurol Sci; 2010 Mar; 290(1-2):177-82. PubMed ID: 20022024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathological basis of semantic dementia.
    Davies RR; Hodges JR; Kril JJ; Patterson K; Halliday GM; Xuereb JH
    Brain; 2005 Sep; 128(Pt 9):1984-95. PubMed ID: 16000337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial frontotemporal dementia: a report of three cases of severe cerebral atrophy with rare inclusions that are negative for tau and synuclein, but positive for ubiquitin.
    Chang HT; Cortez S; Vonsattel JP; Stopa EG; Schelper RL
    Acta Neuropathol; 2004 Jul; 108(1):10-6. PubMed ID: 15108011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical entity of frontotemporal dementia with motor neuron disease.
    Mitsuyama Y; Inoue T
    Neuropathology; 2009 Dec; 29(6):649-54. PubMed ID: 19780984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between extramotor ubiquitin-immunoreactive neuronal inclusions and dementia in motor neuron disease.
    Mackenzie IR; Feldman H
    Acta Neuropathol; 2003 Feb; 105(2):98-102. PubMed ID: 12536219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage and activated caspase-3 expression in neurons and astrocytes: evidence for apoptosis in frontotemporal dementia.
    Su JH; Nichol KE; Sitch T; Sheu P; Chubb C; Miller BL; Tomaselli KJ; Kim RC; Cotman CW
    Exp Neurol; 2000 May; 163(1):9-19. PubMed ID: 10785439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolution and pathology of frontotemporal dementia.
    Kertesz A; McMonagle P; Blair M; Davidson W; Munoz DG
    Brain; 2005 Sep; 128(Pt 9):1996-2005. PubMed ID: 16033782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration.
    Lipton AM; White CL; Bigio EH
    Acta Neuropathol; 2004 Nov; 108(5):379-85. PubMed ID: 15351890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A clinicopathological study on 13 cases of motor neuron disease with dementia].
    Yoshida M; Murakami N; Hashizume Y; Takahashi A
    Rinsho Shinkeigaku; 1992 Nov; 32(11):1193-202. PubMed ID: 1301319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.
    Josephs KA; Petersen RC; Knopman DS; Boeve BF; Whitwell JL; Duffy JR; Parisi JE; Dickson DW
    Neurology; 2006 Jan; 66(1):41-8. PubMed ID: 16401843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontotemporal lobar degeneration: clinical and pathological relationships.
    Snowden J; Neary D; Mann D
    Acta Neuropathol; 2007 Jul; 114(1):31-8. PubMed ID: 17569065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.